维梧资本投资Zenas Biopharma的1.18亿美元融资,以推进公司的自身免疫疾病治疗产品管线 Gallery 维梧资本投资Zenas Biopharma的1.18亿美元融资,以推进公司的自身免疫疾病治疗产品管线 中国投资项目 维梧资本投资Zenas Biopharma的1.18亿美元融资,以推进公司的自身免疫疾病治疗产品管线 2022-11-10 15:20:20 11月 10日, 2022 | 阅读更多
维梧人民币基金完成对济元基因A轮亿元投资 Gallery 维梧人民币基金完成对济元基因A轮亿元投资 中国投资项目 维梧人民币基金完成对济元基因A轮亿元投资 2022-10-24 16:22:34 10月 24日, 2022 | 阅读更多
NMPA Approves Suzhou Omni’s Compound Ipratropium Bromide Solution for Inhalation to Treat Symptoms of COPD and Asthma Gallery NMPA Approves Suzhou Omni’s Compound Ipratropium Bromide Solution for Inhalation to Treat Symptoms of COPD and Asthma 中国投资项目 NMPA Approves Suzhou Omni’s Compound Ipratropium Bromide Solution for Inhalation to Treat Symptoms of COPD and Asthma 2022-10-01 20:55:09 10月 01日, 2022 | 阅读更多
FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older Gallery FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older 维梧新闻 FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older 2022-08-03 13:49:10 08月 03日, 2022 | 阅读更多
Serán Bioscience Announces Investment by Vivo Capital Gallery Serán Bioscience Announces Investment by Vivo Capital 维梧新闻 Serán Bioscience Announces Investment by Vivo Capital 2022-03-11 16:21:32 03月 11日, 2022 | 阅读更多
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China Gallery VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China 维梧新闻 VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China 2022-03-09 14:40:55 03月 09日, 2022 | 阅读更多